Literature DB >> 17825894

Defective T-cell activation caused by impairment of the TNF receptor 2 costimulatory pathway in common variable immunodeficiency.

Rosa M Aspalter1, Martha M Eibl, Hermann M Wolf.   

Abstract

BACKGROUND: Patients with common variable immunodeficiency have defective T-cell activation after stimulation via T-cell receptor (TCR)/CD28 or by recall antigens.
OBJECTIVE: In the current study, we investigated whether TNF-receptor 2 (RII) costimulation, which is important for sufficient TCR/CD28 stimulation, was significantly impaired in common variable immunodeficiency (CVID).
METHODS: We studied T-cell activation events such as CD69 induction, calcium flux through store operated calcium channels, protein kinase C-theta translocation, and costimulation via TNF-RII compared with costimulation via CD28.
RESULTS: By measuring TNF receptor-associated factor 1 expression, which is induced by TCR alone and can be upregulated by either CD28 or TNF-RII costimulation, we show that costimulation via CD28 is intact, whereas costimulation via TNF-RII in these patients is impaired. The ras-activation pathway as tested by CD69 induction, calcium flux through store operated calcium channels, and protein kinase C-theta translocation were comparable in CVID and control T cells.
CONCLUSION: Taken together, these data indicate that the primary TCR signal as well as the signal derived from CD28 are normal but that TNF-RII-supported TCR costimulation is defective, most likely leading to impairment of an important amplification loop, such as TNF-RII augmented nuclear factor-kappaB activation. CLINICAL IMPLICATIONS: The finding of defective TNF-RII cosignaling in patients with CVID may help to define the activation pathway affected, thus potentially leading to a characterization of the molecular defect and molecular diagnosis in at least some of these patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17825894     DOI: 10.1016/j.jaci.2007.07.004

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  8 in total

1.  T-cell response to viral antigens in adults and children with common variable immunodeficiency and specific antibody deficiency.

Authors:  L M Haveman; J Scherrenburg; L J Maarschalk-Ellerbroek; P D Hoek; R Schuurman; W de Jager; P M Ellerbroek; B J Prakken; D van Baarle; J M van Montfrans
Journal:  Clin Exp Immunol       Date:  2010-04-09       Impact factor: 4.330

2.  Surface Plasmon Resonance Analysis Shows an IgG-Isotype-Specific Defect in ABO Blood Group Antibody Formation in Patients with Common Variable Immunodeficiency.

Authors:  Michael B Fischer; Wendelin Wolfram; Christoph J Binder; Georg A Böhmig; Markus Wahrmann; Martha M Eibl; Hermann M Wolf
Journal:  Front Immunol       Date:  2015-05-06       Impact factor: 7.561

3.  Leaky RAG Deficiency in Adult Patients with Impaired Antibody Production against Bacterial Polysaccharide Antigens.

Authors:  Christoph B Geier; Alexander Piller; Angela Linder; Kai M T Sauerwein; Martha M Eibl; Hermann M Wolf
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

4.  In Vivo PET Imaging of the Activated Immune Environment in a Small Animal Model of Inflammatory Arthritis.

Authors:  Benjamin L Franc; Sam Goth; John MacKenzie; Xiaojuan Li; Joseph Blecha; Tina Lam; Salma Jivan; Randall A Hawkins; Henry VanBrocklin
Journal:  Mol Imaging       Date:  2017-01-01       Impact factor: 4.488

5.  Hypomorphic Mutations in the BCR Signalosome Lead to Selective Immunoglobulin M Deficiency and Impaired B-cell Homeostasis.

Authors:  Christoph B Geier; Kai M T Sauerwein; Alexander Leiss-Piller; Isabella Zmek; Michael B Fischer; Martha M Eibl; Hermann M Wolf
Journal:  Front Immunol       Date:  2018-12-18       Impact factor: 7.561

Review 6.  Targeting Regulatory T Cells by Addressing Tumor Necrosis Factor and Its Receptors in Allogeneic Hematopoietic Cell Transplantation and Cancer.

Authors:  Harald Wajant; Andreas Beilhack
Journal:  Front Immunol       Date:  2019-08-28       Impact factor: 7.561

7.  Antigen-Specific CD4+ T-Cell Activation in Primary Antibody Deficiency After BNT162b2 mRNA COVID-19 Vaccination.

Authors:  Kai M T Sauerwein; Christoph B Geier; Roman F Stemberger; Hüseyin Akyaman; Peter Illes; Michael B Fischer; Martha M Eibl; Jolan E Walter; Hermann M Wolf
Journal:  Front Immunol       Date:  2022-02-14       Impact factor: 7.561

8.  TNFR2 expression by CD4 effector T cells is required to induce full-fledged experimental colitis.

Authors:  Xin Chen; Yingjie Nie; Haitao Xiao; Zhaoxiang Bian; Anthony J Scarzello; Na-Young Song; Anna L Trivett; Joost J Oppenheim
Journal:  Sci Rep       Date:  2016-09-07       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.